Group FPGC (mg/dL)
NORM 86.30 ± 0.15n
DIAB 368.20 ± 0.72a
HrACMO 133.00 ± 0.63b
HrASGA 105.70 ± 0.71e,f,g,h
HrEMCO 118.00 ± 0.92c,d
HrHIRO 112.50 ± 0.70d,e
HrAGAM 66.30 ± 0.71q
HrAGEC 81.00 ± 0.39n,o,p
HrAGHR 112.50 ± 0.42d,e,f
HrAMEC 97.20 ± 0.51l,m
HrAMHR 105.00 ± 0.62e,f,g,h,i
HrECHR 103.50 ± 0.79f,g,h,i,j
HrAGEH 103.00 ± 0.81f,g,h,i,j,k
HrAMAE 84.70 ± 0.51n,o
HrAMAH 124.30 ± 0.92c
HrAMEH 112.00 ± 0.71d,e,f,g
HrAAEH 97.30 ± 0.85l
The mean (X) ± S.D of six (n = 6) determinations. Means in the column with the same letter are not significantly different at p>0.05 according to LSD. FPGC>110 mg/dL = hyperglycemia.
Table 1: Fasting plasma glucose concentrations of normal, diabetic and treated
rats.